2013
Fractal organization of the human T cell repertoire in health and after stem cell transplantation., Jeremy Meier, Catherine Roberts, Kassi Avent, Allison Hazlett, Jennifer Berrie, Kyle Payne, David Hamm, Cindy Desmarais, Catherine Sanders, Kevin T Hogan, Kellie J Archer, Masoud H Manjili, and Amir Toor MD (Article)
Melanoma Update, Suresh G. Nair MD (Presentation)
Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2, Michael p. O'Connell; Katie Marchbank; Marie R. Webster; Alexander A. Valiga; Amanpreet Kaur; Adina Vultur; Ling Li; Meenhard Herlyn; Jessie Villanueva; Qin Liu; Xiangfan Yin; Sandy Widura; Janelle Nelson; Nivia Ruiz; Tura C. Camilli; Fred E. Indig; Keith T. Flaherty; Jennifer A. Wargo; Dennie T. Frederick; Zachary A. Cooper; Suresh G. Nair MD; Ravi K. Amaravadi; Lynn M. Schuchter; Giorgos C. Karakousis; Wei Xu; Xiaowei Xu MD, PhD; and Ashani T. Weeraratna (Article)
Diabetic Ketoacidosis: A Review and Update, Gretchen Perilli MD, Christine Saraceni, Michael N. Daniels DO, and Aakif N. Ahmad DO (Article)
Plasmablastic Lymphoma of the Maxillary Sinus in an HIV-negative Patient: a Case Report and Literature Review, Christine Saraceni, Nicole M. Agostino DO, Dennis B. Cornfield MD, and Ranju Gupta MD (Article)
Fatal malignant metastastic epithelioid angiomyolipoma presenting in a young woman: case report and review of the literature., Edward Wyluda, Giselle Baquero, Nicholas Lamparella DO, Catherine Abendroth, and Joseph Drabick (Article)
Early-Phase Clinical Trials in the Community: Results from the National Cancer Institute Community Cancer Centers Program Early-Phase Working Group Baseline Assessment., Howard A. Zaren, Suresh G. Nair MD, Ronald S. Go, Rebecca A. Enos, Keith S. Lanier, Michael A. Thompson, Jinxiu Zhao, Deborah L. Fleming, John C. Leighton, Thomas E. Gribbin, Donna M. Bryant, Angela Carrigan, Jennifer C. Corpening, Kimberly A. Csapo, Eileen P. Dimond, Christie Ellison, Maria M. Gonzalez, Jodi L. Harr, Kathy Wilkinson, and Andrea M. Denicoff (Article)
2012
Cediranib (AZD2171) in Patients With Advanced Hepatocellular Carcinoma: A Phase II North Central Cancer Treatment Group Clinical Trial, Steven R. Alberts MD, MPH; Tom R. Fitch MD; George P. Kim MD; Bruce W. Morlan MS; Shaker R. Dakhil MD; Howard M. Gross MD; and Suresh G. Nair MD (Article)
Effect of Oxaliplatin, Fluorouracil, and Leucovorin with or Without Cetuximab on Survival Among Patients with Resected Stage III Colon Cancer: A Randomized Trial., Steven R. Alberts MD, MPH; Daniel J. Sargent; Suresh G. Nair MD; Michelle R. Mahoney; Margaret Mooney; Stephen N. Thibodeau; Thomas C. Smyrk; Frank A. Sinicrope; Emily Chan; Sharlene Gill; Morton S. Kahlenberg; Anthony F. Shields; James T. Quesenberry; Thomas A. Webb; Gist H. Farr; Barbara A. Pockaj; Axel Grothey; and Richard M. Goldberg (Article)
Distinct oligoclonal T cells are associated with graft versus host disease after stem-cell transplantation., Jennifer L Berrie, Maciej Kmieciak, Roy T Sabo, Catherine H Roberts, Michael O Idowu, Katherine Mallory, Harold M Chung, John M McCarty, Christian A Borrelli, Michelle M Detwiler, A Latif Kazim, Amir Toor MD, and Masoud H Manjili (Article)
Philadelphia Chromosome-Negative Myeloproliferative Neoplasm with a Novel Platelet-Derived Growth Factor Receptor-β Rearrangement Responsive to Imatinib, Dennis B. Cornfield MD, Usman Shah MD, Nicholas Cross, Courtney E. Bennett DO, and Guoxian Sun (Article)
Utility of FDG PET-CT Scan in Determining Pathological Response to Neo-adjuvant Chemo-radiation Therapy in Non-small Cell Lung Cancer (NSCLC), Eliot L. Friedman MD, Michael F. Szwerc MD, Robert Kruklitis MD, Michael J. Weiss MPH, Robert Rienzo MD, and Wen Young MD (Poster)
Early-phase (EP) clinical trials (CTs) in the community: Results from the National Cancer Institute (NCI) Community Cancer Centers Program (NCCCP) Early-Phase Working Group (EPWG) Baseline Assessment Study (BAS)., Ronald S. Go, Howard Zaren, and Suresh G. Nair MD (Presentation)
Immunotherapy of cancer: reprogramming tumor-immune crosstalk., Kyle K Payne, Amir Toor MD, Xiang-Yang Wang, and Masoud H Manjili (Article)
Community Cancer Services, Clinical Trials, and Quality Initiatives--Year 2 NCCCP at Lehigh Valley Health Network, Ada M. Rivera BA; Lenore A. McGonigle Ms; MaryEllen Shiels BS; Smiyyah Q. Whitney RN; Suresh G. Nair MD; Janelle M. Sharma; Kathy Sevedge RN, MA, AOCN; Eliot L. Friedman MD; Nadesda Mack RN, BSN, MBA, OCN; and Gregory R. Harper MD, PhD (Poster)
Perceived levels of pain associated with bone marrow aspirates and biopsies., Giampaolo Talamo, Jason Liao, Jamal Joudeh, Nicholas Lamparella DO, Hoang Dinh, Jozef Malysz, and W Christopher Ehmann (Article)
Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity., Amir Toor MD, Kyle K Payne, Harold M Chung, Roy T Sabo, Allison F Hazlett, Maciej Kmieciak, Kimberly Sanford, David C Williams, William B Clark, Catherine H Roberts, John M McCarty, and Masoud H Manjili (Article)
Favorable outcomes in patients with high donor-derived T cell count after in vivo T cell-depleted reduced-intensity allogeneic stem cell transplantation., Amir Toor MD, Roy T Sabo, Harold M Chung, Catherine Roberts, Rose H Manjili, Shiyu Song, David C Williams, Wendy Edmiston, Mandy L Gatesman, Richard W Edwards, Andrea Ferreira-Gonzalez, William B Clark, Michael C Neale, John M McCarty, and Masoud H Manjili (Article)
2011
Transformation of the 5q- Syndrome to Acute Lymphoblastic Leukemia: A Report of Two Cases and Review of the Literature, Nicole M. Agostino DO, Basil Ahmed MD, Dan Popescu MD, and Shereen M. Gheith MD (Article)
Effect of the Tyrosine Kinase Inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on Blood Glucose Levels in Diabetic and Nondiabetic Patients in General Clinical Practice, Nicole M. Agostino DO; Vernon M. Chinchilli PhD; Christopher J. Lynch PhD; Anita M. Koszyk-Szewczyk MD; Rebecca Gingrich RN, MS, OCN; Jeffrey Sivik D Pharma; and Joseph J. Drabick MD, FACP (Article)
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043)., Kenneth I Ataga, Marvin Reid, Samir K Ballas, Zahida Yasin, Carolyn Bigelow, Luther St James, Wally R Smith, Frederic Galacteros, Abdullah Kutlar, James H Hull, Jonathan W Stocker, and Maged Khalil MD (Article)
Mid-term Analysis of IIIA NSCLC Patients Treated With Neoadjuvant Chemoradiation Followed by Surgical Resection, Eliot L. Friedman MD (Presentation)
Neo-adjuvant Chemotherapy and Radiation Therapy in Patients with Stage IIIA (N2) Non-Small Cell Lung Cancer (NSCLC): A Retrospective Analysis with Lessons Learned, Eliot L. Friedman MD, Michael F. Szwerc MD, Charles Andrews MD, Robert Kruklitis MD, Kathleen A. Leies, and Ferdy Santiago (Poster)
Community Cancer Services, Clinical Trials, and Quality Initiatives—Year 1 NCCCP at Lehigh Valley Health Network, Gregory R. Harper MD, PhD; Ada M. Rivera BA; Eliot L. Friedman MD; Kathleen A. Leies RN, OCN; Nadesda Mack RN, BSN, MBA, OCN; Lenore McGonigle Med; Suresh G. Nair MD; Tara Namey MS, CGC; Debbie Salas-Lopez MD, MPH, FACP; and Ronald W. Swinfard MD, FACP (Poster)
Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse., Maciej Kmieciak, Debasmita Basu, Kyle K Payne, Amir Toor MD, Adly Yacoub, Xiang-Yang Wang, Lisa Smith, Harry D Bear, and Masoud H Manjili (Article)
Ex vivo expansion of tumor-reactive T cells by means of bryostatin 1/ionomycin and the common gamma chain cytokines formulation., Maciej Kmieciak, Amir Toor MD, Laura Graham, Harry D Bear, and Masoud H Manjili (Article)
Comment on "Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses"., Masoud H Manjili and Amir Toor MD (Article)
Exploring therapeutic decisions in elderly patients with non-small cell lung cancer: results and conclusions from North Central Cancer Treatment Group Study N0222., Heidi Mc Kean, Philip J Stella, Shauna L Hillman, Kendrith M Rowland, Michael W Cannon, Robert J Behrens, Gerald G Gross, Mark D Sborov, Eliot L. Friedman MD, and Aminah Jatoi (Article)
2010
Effect of the Tyrosine Kinase Inhibitors (Sunitinib, Sorafenib, Dasatinib, and Imatinib) on Blood Glucose Levels in Diabetic and Non-diabetic Patients in General Clinical Practice (Poster), Nicole M. Agostino DO; Vernon M. Chinchilli PhD; Christopher J. Lynch PhD; Anita M. Koszyk-Szewczyk MD; Rebecca Gingrich RN, MS, OCN; Jeffery Sivik D Pharma; and Joseph J. Darbick MD, FACP (Poster)
Bevacizumab Demonstrates Prolonged Disease Stabilization in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma: A Case Series and Review of the Literature, Nicole M. Agostino DO and Rebecca Gingrich (Article)
A Front-Line Window of Opportunity Phase 2 Study of Sorafenib in Patients with Advanced Nonsmall Cell Lung Cancer: North Central Cancer Treatment Group Study N0326., Grace K. Dy, Shauna L. Hillman, Kendrith M. Rowland, Julian R. Molina, Preston D. Steen MD, Donald B. Wender, Suresh G. Nair MD, Sumithra Mandrekar, Steven E. Schild, and Alex A. Adjei (Article)
Multidisciplinary Survivorship Care, Sue N. Gardner RN, MSN, CRNP, AOCNP; Gregory Harper MD, PhD; Dorothy Morrone RNC, MS, OCN; Jennifer Brennan RD, CSO; Andrea Geshan RN, MSW; Diane Brong LCSW; and Jennifer Roeder MSPT, MBA (Poster)
Randomized phase III trial of pegfilgrastim versus filgrastim after autologus peripheral blood stem cell transplantation., Aaron Gerds, Mary Fox-Geiman, Kevin Dawravoo, Tulio Rodriguez, Amir Toor MD, Scott Smith, Karen Kiley, Donna Fletcher-Gonzalez, Chindo Hicks, and Patrick Stiff (Article)
Cancer: The Lived Experience of Patients and Families, Lorraine Gyauch MA, RN,CT, CGS (Presentation)
Incorporating Rehabilitation Services into Oncology Site-specific Clinical Practice Guidelines, Kathleen Leies RN, OCN; Kathy Sevedge RN, MA, AOCN; Dorothy Morrone RNC, MS, OCN; Stephanie Marshall CCER; and Jennifer Roeder MSPT, MBA (Poster)
Immunologic Therapy with Cadi-05 for the Treatment of Advanced Melanoma, Paul J. Mosca MD, PhD; Suresh G. Nair MD; Susan K. Ayre RN, MA; Wenjing Shi RN, MS; Sherrine Eid MPH; Shantu Amin PhD; Dhimant Desai PhD; Joseph J. Drabick MD, FACP; Bakulesh M. Khamar MD; Arati Sharma PhD; Svetomir N. Markovic MD; and Gavin P. Robertson PhD (Poster)
Adjuvant mFOLFOX6 plus or minus cetuximab (Cmab) in patients (pts) with KRAS mutant (m) resected stage III colon cancer (CC): NCCTG Intergroup Phase III Trial N0147, Suresh G. Nair MD; Richard M. Goldberg; Daniel J. Sargent; Stephen N. Thibodeau; Margaret R. Mahoney; Anthony F. Sheilds; Emily Chan; Sharlene Gill; Morton S. Kahlenberg; and Steven R. Alberts MD, MPH (Presentation)
Identification of Issues Faced by Cancer Survivors, Kathy Sevedge RN, MA, AOCN (Poster)
Patient Navigation: Past, Present and Future, Kathy Sevedge RN, MA, AOCN (Presentation)
2009
Training Tomorrow’s Providers and Expanding Access to Peginterferon/Ribavirin Combination Therapyfor Chronic Hepatatis C in Underinsured/Uninsured Patients: Final Outcomes of a Pilot, Resident-Initiated, Multidisciplinary, Hepatitis C Clinic, Nicole M. Agostino DO; Suzanne J. Templer DO; Edward Norris MD, FAPM; Charles M. Brooks MD; Eric J. Gertner MD, MPH; and Joseph L. Yozviak DO, FACP (Poster)
Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding., Hongan Le, Sheetal Singh, Shyh-Jen Shih, Nga Du, Sabine Schnyder, Grace A Loredo, Christine Bien, Laura Michaelis, Amir Toor MD, Manuel O Diaz, and Andrew T Vaughan (Article)
Acute Splenic Infarct in Beta-Thalassemia Minor: A Novel Combination of Heterozygous Beta-Globin Mutations With Latent Phenotypes and the Clinical Implications, Danny C. Liaw, Adam J. Kotkiewicz, and Mark A. Kender (Article)
Dose intense therapy for relapsed lymphoproliferative disorders: the more things change, the more they are the same., Amir Toor MD (Article)
Impaired NHEJ function in multiple myeloma., Clara Yang, Christopher Betti, Sheetal Singh, Amir Toor MD, and Andrew Vaughan (Article)
2008
Psychiatric Outcomes in a Resident-Run Multidisciplinary Hepatitis C Clinic, Nicole M. Agostino DO; Edward Norris MD, FAPM; Joseph L. Yozviak DO, FACP; Charles M. Brooks MD; Eric J. Gertner MD, MPH; and Michael Kaufmann MD (Poster)
Can Surgeons Improve Survival in Stage IV Melanoma?, Paul J. Mosca MD, PhD; Erik J. Teicher MD; Suresh G. Nair MD; and Barbara A. Pockaj (Article)
Targeting Intracellular Signaling Pathways in Soft Tissue Sarcoma (STS)., Suresh G. Nair MD, Abhishek Sharma, and Amin S. Robertson (Poster)
2007
Current Immunotherapeutic Strategies in Malignant Melanoma., Nicole Agostino DO; Arjumand Ali MD; Suresh G. Nair MD; and Paul J. Mosca MD, PhD (Article)
Outcomes of Peginterferon alfa-2a and Ribavirin Combination Therapy in a Resident-Initiated, Multidisciplinary, Hepatitis C Clinic, Nicole M. Agostino DO; Erini Vasiliadis DO; K Nadeem Ahmed MD; Suzanne J. Templer DO; Edward R. Norris MD, FAPA, FAPM; Charles M. Brooks MD; Eric J. Gertner MD, MPH; and Joseph L. Yozviak DO, FACP (Poster)
Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphoma., Henry C Fung, Patrick Stiff, Jeff Schriber, Amir Toor MD, Eileen Smith, Tulio Rodriguez, Amrita Krishnan, Arturo Molina, David Smith, Barbara Ivers, Neil Kogut, Leslie Popplewell, Roberto Rodriguez, George Somlo, Stephen J Forman, and Auayporn Nademanee (Article)
Alefacept in corticosteroid refractory graft versus host disease: early results indicate promising activity., Amir Toor MD, Patrick J Stiff, Brian J Nickoloff, Tulio Rodriguez, Jared L Klein, and Kenneth B Gordon (Article)
2006
Psychiatric Outcomes in a Resident-run, Multidisciplinary, Hepatitis C Clinic (Poster), Nicole M. Agostino DO; Edward Norris MD, FAPM; Joseph L. Yozviak DO, FACP; Suzanne J. Templer DO; Charles M. Brooks MD; Eric J. Gertner MD, MPH; and Michael Kaufmann MD (Poster)
A Phase II NCCTG Study of Irinotecan and Docetaxel in Previously Treated Patients with Non-Small Cell Lung Cancer., Julian R. Molina, Daniel Nikcevich, Shauna L. Hillman, Susan Geyer, Timothy Drevyanko, James Jett, Joseph Verdirame, Henry Tazelaar, Kendrith M. Rowland, Edward Wos, Leila Kutteh, Suresh G. Nair MD, Tom R. Fitch, Patrick Flynn, Philip J. Stella MD, and Alex A. Adjei (Article)
Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma., Katherine E. Posther, M Angelica Selim, Paul J. Mosca, Wilma E. Stanley, Jeffrey L. Johnson, Douglas S. Tyler MD, and Hilliard F. Seigler MD (Article)
Cultural Compentency and Cancer, Debbie Salas-Lopez MD, MPH (Presentation)
The administration of polymerized human hemoglobin (Pyridoxylated) to a Jehovah's Witness after submyeloablative stem cell transplantation complicated by delayed graft failure., Scott E Smith, Amir Toor MD, Tulio Rodriguez, and Patrick Stiff (Article)
Cardiac nonamyloidotic immunoglobulin deposition disease., Amir Toor MD, Ben A Ramdane, Jacob Joseph, Maria Thomas, Carl O'Hara, Bart Barlogie, Patrick Walker, and Lija Joseph (Article)
Expanding Access to Care through a Resident-Initiated Hepatitis C Clinic - An Innovative Method for Incorporating ACGME Core Competencies into the Management of Medically Underserved Patients, Joseph L. Yozviak DO, FACP; Suzanne J. Templer DO; Erini Vasiliadis DO; Vishal Patel MD; Nicole M. Agostino DO; K Nadeem Ahmed MD; Edward Norris MD, FAPM; Charles M. Brooks MD; and Eric J. Gertner MD, MPH (Poster)
2005
Oxaliplatin, Fluorouracil, and Leucovorin for Patients with Unresectable Liver-Only Metastases from Colorectal Cancer: A North Central Cancer Treatment Group Phase II Study., Steven R. Alberts MD, MPH; William L. Horvath; William C. Sternfeld; Richard M. Goldberg; Michelle R. Mahoney; Shaker R. Dakhil MD; Ralph Levitt MD; Kendrith M. Rowland; Suresh G. Nair MD; Daniel J. Sargent; and John H. Donohue (Article)
Predictors of outcome after hyperthermic isolated limb perfusion: role of tumor response., Thomas A. Aloia MD; Elizabeth Grubbs MD; Mark Onaitis MD; Paul J. Mosca MD, PhD; Tsung-Yen Cheng MD; Hilliard F. Seigler MD; and Douglas S. Tyler MD (Article)
Perceived Quality of Life Among Smokers in Smoking Cessation Therapy., I Croghan, Jeff A. Sloan, R D. Hurt, G A. Croghan, Shaker R. Dakhil MD, Paul J. Novotny, D Schroeder, Edward J. Wos, Kendrith M. Rowland, and Suresh G. Nair MD (Article)
Should Elderly Non-Small-Cell Lung Cancer Patients be Offered ElderlySpecific Trials? Results of a Pooled Analysis from the North Central Cancer Treatment Group., Aminah Jatoi, Shauna L. Hillman, Philip J. Stella MD, Erin Green, Alex A. Adjei, Suresh G. Nair MD, Edith A. Perez MD, Bipinkur Amin, Steven E. Schild, Rene Castillo, and James R. Jett (Article)
Hepatocellular carcinoma in an African American man with a noncirrhotic liver presented initially as an occipital mass., Maged Khalil MD, Padjama Sai, Zili He, Ashraf Aziz, William Steier, Shetra Sivamurthy, Ming Liu, and Madhumati Kalavar (Article)
Epithelioid Angiosarcoma of the Small Intestine After Occupational Exposure to Radiation and Polyvinyl Chloride: A case Report and Review of Literature., Maged Khalil MD, Asha Thomas, Adel Aassad, Moshe Rubin, and Robert N Taub (Article)
Randomized Phase II Trial of Three Schedules of Pemetrexed and Gemcitabine as Front-Line Therapy for Advanced Non-Small-Cell Lung Cancer., Cynthia X Ma, Suresh G. Nair MD, Sachdev Thomas, Sumithra J. Mandrekar, Daniel A. Nikcevich, Kendrith M. Rowland, Tom R. Fitch MD, Harold E. Windschitl, Shauna L. Hillman, Steven E. Schild, James R. Jett, Coleman Obasaju, and Alex A. Adjei (Article)
Factors that Influence Colorectal Cancer Screening Practice in the Latino Community, Ana Natale-Pereira MD, MPH; Marielos Vega RN, BSN; Jonnie Marks PhD; Debbie Salas-Lopez MD, MPH; and M S. Johnson (Presentation)
Perspectives on Cancer Screening Among Internal Medicine Residents and Latino Community Members: A Work in Progress, Debbie Salas-Lopez MD, MPH; Dawne M. Mouzon MPH; Ana Natale-Pereira MD, MPH; Vincent J. Barba; John Kolassa; Jonnie Marks PhD; and Maria L. Soto-Greene MD (Presentation)
2004
Gemcitabine and ISIS-2503 for Patients with Locally Advanced or Metastatic Pancreatic Adenocarcinoma: A North Central Cancer Treatment Group Phase II Trial., Steven R. Alberts MD, MPH; Mark Schroeder; Charles Erlichman; Preston D. Steen MD; Nathan R. Foster; Dennis F. Moore; Kendrith M. Rowland; Suresh G. Nair MD; Loren K. Tschetter; and Tom R. Fitch MD (Article)
Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines., Christiane Houde, Yulin Li, Lynda Song, Kevin Barton, Qing Zhang, John Godwin, Sucha Nand, Amir Toor MD, Serhan Alkan, N Veronique Smadja, Hervé Avet-Loiseau, Carmen S Lima, Lucio Miele, and Lionel J Coignet (Article)
Investigating Four 'Myths' Surrounding Dysphagia in Patients with Metastatic Esophageal Cancer. A Multi-Institutional Study from the North Central Cancer Treatment Group., Aminah Jatoi, Nathan R. Foster, P Johnson, George G. Klee, J F Quevedo, Roscoe F. Morton MD, Suresh G. Nair MD, Carl G. Kardinal MD, and James A. Mailliard MD (Article)
An Eicosapentaenoic Acid Supplement Versus Megestrol Acetate Versus Both for Patients with Cancer-Associated Wasting: A North Central Cancer Treatment Group and National Cancer Institute of Canada Collaborative Effort., Aminah Jatoi, Kendrith M. Rowland, Charles L. Loprinzi, Jeff A. Sloan, Shaker R. Dakhil MD, Neil MacDonald, Bruno Gagnon, Paul J. Novotny, James A. Mailliard MD, Teresita I L Bushey, Suresh G. Nair MD, and Brad Christensen (Article)
Oral Vinorelbine for the Treatment of Metastatic Non-Small Cell Lung Cancer in Elderly Patients: A Phase II Trial of Efficacy and Toxicity., Anne Kanard, Aminah Jatoi, Rene Castillo, Susan Geyer, Thomas K. Schulz, Tom R. Fitch MD, Kendrith M. Rowland, Suresh G. Nair MD, James E. Krook MD, and John W. Kugler MD (Article)
Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis., Maged Khalil MD, William D Wagner, and Ira J Goldberg (Article)
Phase II Evaluation of 96-Hour Paclitaxel Infusion in Advanced (Recurrent or Metastatic) Squamous Cell Carcinoma of the Head and Neck (E3395): a Trial of the Eastern Cooperative Oncology Group., Corey J. Langer, Yi Li, Timothy Jennings, Ronald C. DeConti, Suresh G. Nair MD, Roger B. Cohen, and Arlene A. Forastiere (Article)
Post-transplant air-leak syndrome., Tawee Tanvetyanon, Amir Toor MD, and Patrick J Stiff (Article)
Favourable results with a single autologous stem cell transplant following conditioning with busulphan and cyclophosphamide in patients with multiple myeloma., Amir Toor MD, John Ayers, Joan Strupeck, Mala Parthasarathy, Steve Creech, Tulio Rodriguez, and Patrick J Stiff (Article)
2003
BEAM allogeneic transplantation for patients with Hodgkin's disease who relapse after autologous transplantation is safe and effective., Julian P Cooney, Patrick J Stiff, Amir Toor MD, and Mala Parthasarathy (Article)
Infection--an underappreciated cause of bone pain in multiple myeloma., Raman Desikan, Bart Barlogie, Rajesh Sethi, Amir Toor MD, Dan Spoon, Edward Angtuaco, Rudy Vanhemert, Anantha VijayaGopal, Seema Singhal, Jayesh Mehta, Sundar Jagannath, Nikhil Munshi, Maurizio Zangari, Athanassios Fassas, Guido Tricot, and Elias Anaissie (Article)
Impact of Immediate Reconstruction on the Local Recurrence of Breast Cancer After Mastectomy., Robert X. Murphy JR, MD, MS; Samina Wahhab MD; Peter Rovito MD; Gregory R. Harper MD, PhD; Sharon R. Kimmel; Lawrence C. Kleinman MD, MPH; and Mark J. Young MD (Article)
2002
CPT-11 for Bile-Duct and Gallbladder Carcinoma: A Phase II North Central Cancer Treatment Group (NCCTG) Study., Steven R. Alberts MD, MPH; Paul A. Fishkin; Lawrence J. Burgart; Peter J. Cera; Michelle R. Mahoney; Roscoe F. Morton MD; Patricia A. Johnson; Suresh G. Nair MD; and Richard M. Goldberg (Article)
ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning., Ashraf Badros, Guido Tricot, Amir Toor MD, Christopher Morris, Chuanfa Guo, Nikhil Munshi, Bart Barlogie, and Michele Cottler-Fox (Article)
Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations., Athanasios B-T Fassas, Firas Muwalla, Tanya Berryman, Riad Benramdane, Lija Joseph, Elias Anaissie, Rajesh Sethi, Raman Desikan, David Siegel, Ashraf Badros, Amir Toor MD, Maurizio Zangari, Christopher Morris, Edgardo Angtuaco, Sajini Mathew, Carla Wilson, Aubrey Hough, Sami Harik, Bart Barlogie, and Guido Tricot (Article)
Efficacy and Toxicity of Adjuvant Chemotherapy in Elderly Patients with Colon Carcinoma: A 10-Year Experience of the Geisinger Medical Center., Farid Fata, Ayoub Mirza, G Craig, Suresh G. Nair MD, Amy Law, James Gallagher, Neil Ellison, and Albert M. Bernath MD (Article)
A Phase II Trial of Docetaxel and CPT-11 in Patients with Metastatic Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia., Aminah Jatoi; Marisa Tria Tirona; Steven S. Cha; Steven R. Alberts MD, MPH; Kendrith M. Rowland; Roscoe F. Morton MD; Suresh G. Nair MD; Carl G. Kardinal MD; Philip J. Stella MD; James A. Mailliard MD; Daniel J. Sargent; and Richard M. Goldberg (Article)
Microscale assay for screening of inhibitory activity of Lactobacillus., Bradley Lash, Hassan Gourama, and Tami H Mysliwiec (Article)
Long-Term Survival of Patients with Advanced/Recurrent Carcinoma of Cervix and Vagina After Neoadjuvant Treatment with Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with or without the Addition of Molgramostim, and Review of the Literature., Harry J. Long, Sandra Rayson, Karl C. Podratz, Samir Abu-Ghazaleh, Vera J. Suman PhD, Lynn C. Hartmann MD, Ralph Levitt MD, Suresh G. Nair MD, Alan K. Hatfield MD, and James A. Knost (Article)
A phase II study of Paclitaxel and Cisplatin for Extensive Stage Small Cell Lung Cancer., Randolph S. Marks MD and Suresh G. Nair MD (Article)
Women Experience Greater Toxicity with Fluorouracil-Based Chemotherapy for Colorectal Cancer., Jeff A. Sloan, Richard M. Goldberg, Daniel J. Sargent, Delfino Vargas-Chanes, Suresh G. Nair MD, Steven S. Cha, Paul J. Novotny, Michael A. Poon, Michael J. O'Connell, and Charles L. Loprinzi (Article)
Predicting long-term (> or = 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants., Guido Tricot, Trey Spencer, Jeffrey Sawyer, Dan Spoon, Raman Desikan, Athanasios Fassas, Ashraf Badros, Maurizio Zangari, Nikhil Munshi, Elias Anaissie, Amir Toor MD, and Bart Barlogie (Article)
2001
Images in clinical medicine. Bilateral ovarian dermoid cysts., Richard Boulay MD and E Podczaski (Article)
2000
A North Central Cancer Treatment Group Phase II Trial of Topotecan in Relapsed Gliomas., Patrick A. Burch MD, Albert M. Bernath MD, Terrence L. Cascino, Bernd W. Scheithauer MD, Paul Novotny, Suresh G. Nair MD, Jan C. Buckner, Delano M. Pfeifle, John W. Kugler MD, and Loren K. Tschetter (Article)
A Phase II Study of Paclitaxel Plus Carboplatin as First-Line Chemotherapy for Women with Metastatic Breast Carcinoma., Edith A. Perez MD, David W. Hillman MS, Philip J. Stella MD, James E. Krook MD, Lynn C. Hartmann MD, Tom R. Fitch MD, Alan K. Hatfield MD, James A. Mailliard MD, Suresh G. Nair MD, Carl G. Kardinal MD, and James N. Ingle MD (Article)
A Randomized Phase II and Pharmacokinetic Study of Dacarbazine in Patients with Recurrent Glioma., S. Vincent Rajkumar MD, Joel M. Reid, Paul J. Novotny, Stephanie L. Safgren, Bernd W. Scheithauer MD, P. Steven Johnson, Suresh G. Nair MD, Roscoe F. Morton MD, Alan K. Hatfield MD, James E. Krook MD, Matthew M. Ames, and Jan C. Buckner (Article)
Sex Differences in Fluorouracil-Induced Stomatitis., Jeff A. Sloan, Charles L. Loprinzi, Paul J. Novotny, Scott H. Okuno MD, Suresh G. Nair MD, and Debra L. Barton (Article)
1999
Alleviation of Gastrointestinal Mucosal Toxicity Related to Chemotherapy and Radiation Therapy: The NCCTG Experience., Scott H. Okuno MD, T Kozelsky, Charles L. Loprinzi, and Suresh G. Nair MD (Article)
Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent glioma., S. Vincent Rajkumar MD, Patrick A. Burch MD, Suresh G. Nair MD, Robert P. Dinapoli MD, Bernd W. Scheithauer MD, Judith R. O'Fallon MD, Paul S. Etzell MD, John M. Leitch MD, Roscoe F. Morton MD, and Randolph S. Marks MD (Article)
1998
Combined Levamisole with Recombinant Interleukin-2 (IL-2) in Patients with Advanced Renal Cell Carcinoma: A Phase II Study., Edward T. Creagan MD, Robert D. Hestorff, Vera J. Suman PhD, James A. Mailliard MD, Suresh G. Nair MD, James E. Krook MD, John W. Kugler MD, Robert F. Marschke, John C. Michalak, and Loren K. Tschetter (Article)
Phase II Trial of Topotecan for the Treatment of Mesothelioma., Andrew W. Maksymiuk, Robert F. Marschke, Henry D. Tazelaar, Joe Grill, Suresh G. Nair MD, Randolph S. Marks MD, B. Jay Brooks, James A. Mailliard MD, G. Mark Burton, and James R. Jett (Article)
Primary Small Cell Anaplastic Carcinoma of the Breast Diagnosed by Fine Needle Aspiration Cytology: A Case Report., Matjaz Sebenik MD, Suresh G. Nair MD, and Husam F. Hamati MD (Article)
1996
Delayed Presentation of Breast Masses and Subsequent Treatment Compliance., Peggy E. Chatham-Showalter MD, Stephanie Knabbe, and Nora Suggs MD (Presentation)